HomeHealthcare & Life SciencesPharmaceuticals Granulomatous Lobular Mastitis Treatment Market

North America Granulomatous Lobular Mastitis Treatment Market Size & Outlook, 2026-2034


North America Granulomatous Lobular Mastitis Treatment Market Insights

  • As per Reed Intelligence insights, North America’s Granulomatous Lobular Mastitis Treatment Market was valued at USD 95.33 Million in 2025 and is anticipated to expand to USD 171.55 Million by 2034.
  • From 2026 to 2034, the market is anticipated to expand at a CAGR of 6.75%.
  • Within Treatment Type, Corticosteroid Therapy accounted for the largest market size in 2025.
  • During the forecast period, Antibiotic Therapy is anticipated to remain the highest-growth segment within the Treatment Type category.

Other Key Findings


  • North America held 30.55% share of the global Granulomatous Lobular Mastitis Treatment Market size in 2025.
  • United States is expected to remain the largest contributor to the global market size by 2034.
  • By 2034, Canada is anticipated to record the highest growth in North America, with the market size expected to reach USD 51.9 Million.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 95.33 Million
Market Size In 2034 USD 171.55 Million
Largest segment Corticosteroid Therapy
Units Revenue in USD Million
CAGR 6.75% (2026-2034)
Segmnetation Covered
North America
  1. United States
  2. Canada
Treatment Type
  1. Corticosteroid Therapy
  2. Immunosuppressive Therapy
  3. Antibiotic Therapy
  4. Surgical Treatment
Diagnosis Method
  1. Biopsy
  2. Ultrasound Imaging
  3. Magnetic Resonance Imaging (MRI)
  4. Mammography
End-Use
  1. Hospitals
  2. Specialty Clinics
  3. Diagnostic Centers
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports